STOCK TITAN

ESAB Corp 10-Q Filings

ESAB NYSE

Every 10-Q that ESAB Corp (ESAB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ESAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ESAB filings page.

Rhea-AI Summary

ESAB Corporation reported higher net sales but lower profitability for the quarter ended July 3, 2026. Net sales rose to $807.6 million from $715.6 million a year earlier, while net income attributable to common stockholders fell to $31.0 million from $66.9 million, with diluted EPS declining to $0.50 from $1.09. The decline reflects higher selling, general and administrative expense, significantly increased restructuring charges, and acquisition-related amortization and transaction costs.

On June 1, 2026 ESAB completed the approximately $1.5 billion acquisition of Eddyfi Holding Inc., adding $21.4 million of net sales in the quarter. The deal was financed with cash, a new $1.0 billion 5.625% senior notes issuance, additional revolver borrowings, and private placements of $175.0 million of 6.50% mandatory convertible preferred stock and $143 million of common stock. Total debt increased to $2.42 billion from $1.24 billion, while operating cash flow for the first half was $80.3 million. ESAB also highlights exposures including Russia, which represented about 5% of net sales and holds roughly $50 million of cash, and long‑term asbestos-related liabilities of $298.9 million offset by substantial insurance assets.

Rhea-AI Summary

ESAB Corporation’s first quarter of 2026 showed higher sales but weaker earnings as the company prepared for a major acquisition. Net sales rose to $745.6 million from $678.1 million, driven by acquisitions and currency tailwinds, while organic volume declined due to tariffs and logistics disruptions.

Net income from continuing operations fell to $51.8 million and diluted EPS from continuing operations held at $0.82, with total diluted EPS at $0.78 versus $1.10 a year earlier. Higher restructuring, acquisition-related costs and interest expense compressed margins, even as Adjusted EBITDA edged up to $136.6 million.

ESAB agreed to acquire Eddyfi Technologies for about $1.45 billion, funding it with new $1.0 billion 2031 senior notes and roughly $318 million of equity, including 6.50% Series A Mandatory Convertible Preferred Stock. Total debt increased to $2.06 billion and cash to $1.00 billion, leaving the company more leveraged ahead of closing.

Rhea-AI Summary

ESAB Corporation filed its Q3 2025 report showing steady top-line growth with softer earnings. Net sales were $727,845,000 versus $673,250,000 a year ago, while operating income was $106,618,000 versus $106,015,000. Net income attributable to ESAB was $54,847,000 versus $68,240,000, and diluted EPS was $0.90 versus $1.11. EMEA & APAC drove most of the sales increase, supported by recent acquisitions.

Year-to-date, net sales reached $2,121,569,000 versus $2,070,047,000, and Adjusted EBITDA was $416,895,000 versus $397,545,000. Cash from operations was $163,514,000; investing used $462,053,000, primarily for acquisitions; financing provided $227,263,000. ESAB completed acquisitions including EWM GmbH, Bavaria, DeltaP and Aktiv, with preliminary consideration of $452,402,000, goodwill of $228,791,000 and identifiable intangibles of $181,079,000.

Debt consisted of a $260,000,000 revolving draw, $375,000,000 Term Loan A-1, and $700,000,000 Senior Notes as of October 3, 2025. Subsequently, ESAB entered an amended credit agreement providing a $350,000,000 term loan and a $1,050,000,000 revolver maturing October 16, 2030. Russia represented approximately 6% of Q3 net sales and $3,000,000 of net income, with about $48,000,000 of cash in-country.

Rhea-AI Summary

ESAB Corporation 10-Q (Quarter ended July 4, 2025)

Net sales were $715.6 million for the quarter and $1,393.7 million for the six months ended July 4, 2025. Net income attributable to ESAB was $66.9 million for the quarter and $134.2 million for the six months; diluted net income per share was $1.09 for the quarter and $2.19 for the six months. Adjusted EBITDA was $143.5 million (quarter) and $277.4 million (six months).

  • Balance sheet: Total assets $4.432 billion; cash and cash equivalents $258.2 million; long-term debt $1,058.8 million (long-term portion).
  • Acquisitions: Completed Bavaria Schweisstechnik (~$68M), DeltaP (~$16M); agreements to acquire Aktiv Technologies (~$29M, closed July 9, 2025) and EWM (~$324M; projected 2025 revenue ~$141M).
  • Currency and translation: Significant positive foreign currency translation recorded in AOCL driving accumulated other comprehensive loss improvement to $(549.7) million at July 4, 2025.
  • Geopolitics: Russia represented ~5% of revenue and ~5% of net assets; ~$48 million of cash in Russia may be subject to withdrawal delays.
  • Cash flow: Net cash provided by operating activities was $82.0 million for six months (down from $127.5 million prior year); net cash used in investing activities $98.5 million (includes acquisitions).